
Sovereign Capital readies Nurse Plus for exit
Sovereign Capital has hired Clearwater International to explore a sale of UK-based healthcare staff agency Nurse Plus, two sources familiar with the situation said.
The company is expected to be marketed off annual EBITDA in the region of GBP 10m-12m, one of the sources and a third source familiar said. Nurse Plus recorded GBP 10m in EBITDA against revenue of GBP 76m in the year ended 31 September 2021, according to filings with Companies House.
Sovereign bought Nurse Plus in 2015 from Key Capital Partners as part of a management buyout. At the time, it had revenues of GBP 35.5m.
Similar businesses in mainland Europe are in the midst of competitive sale processes. Doxx, a German healthcare staffing specialist, saw a long list of midmarket sponsors make non-binding offers in an ongoing sale expected to reach EUR 260m EV hinged on a EUR 15m-EUR 20m EBITDA, as reported. Smaller peer Locum Doctors is also on the block.
Founded in 2005, Nurse Plus provides nursing and care personnel to both the UK’s health and social care sectors. The business is the second-largest provider in its market, operating 50-plus branches from which it recruits, develops and manages a database of more than 2,500 workers who provide over 60,000 hours of care a week.
Clearwater declined to comment. Sovereign Capital and Nurse Plus did not respond to a request for comment.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater